KEYNOTE ADDRESSES:
Philip Campbell, Editor-in-Chief
of Nature and the Nature Publishing Group will deliver the Keynote address
for the 3rd Biennial Schizophrenia International Research
Conference. Dr. Campbell has worked with the UK Office of Science, the
European Commission and the US National Institutes of Health on issues
relating to science and its impacts in society.
PLENARY ADDRESSES:
Four plenary sessions will be featured at the conference. The Plenary sessions will begin with a presentation from the primary speaker, followed by panelists' perspectives on relevant issues. The sessions will conclude with audience discussion.
Topics for the 2012 Plenary sessions are Psychological and Social
treatments, Genetics, Immunology and Experimental Medicine and New
Treatments. To view speaker and speaker presentation topics, go to "Plenary Sessions" under the Science of the Meeting tab.
PLENARY SESSIONS:
(View the schedule and session titles)
- Psychological and Social Treatments -
Chairs: Dawn Velligan and Shitij Kapur
- Genetic - Chairs: Lynn DeLisi and Jim van Os
- Models from Immunology and Experimental Medicine -
Chairs: Carol Tamminga and René Kahn
- New Treatments - Chairs: Wolfgang Fleischhacker, Donald Goff and John Kane
Introductory presentations will be given on the challenges of translating preclinical findings into clinical research and on regulatory practice. Researchers in Industry will provide updates on new compounds and strategic approaches to drug development.
SYMPOSIA SESSIONS:
(View
the schedule and session titles)
The Conference Organizers and Program Committee have selected 35 symposia and 6 workshops for presentation from abstracts submitted.
35 Outstanding symposia were selected by the Program Committee and
Conference Organizers for presentation at the 3rd Biennial Meeting. To view speaker and speaker presentation topics, go to "Symposia Sessions" under the Science of the Meeting tab.
WORKSHOPS:
(View the schedule and session titles)
New for 2012 – seven workshops have been added to the conference schedule. Four concurrent workshops will be offered on Sunday and three evening workshops will be offered on Tuesday following the afternoon sessions. To view speakers and speaker presentation topics, go to "Workshop" under the Science of the Meeting tab.
ORAL SESSIONS:
Six oral sessions featuring eight presentations will be offered. Each oral presentation will be 10 minutes with a 5 minute discussion following the presentation.
LEARNING OBJECTIVES FOR THE CONFERENCE:
After participating in this CME activity, participants should be able to describe and discuss:
- Foster communication and advance knowledge about the multiple treatment possibilities for schizophrenia.
-
Develop the best methods to design new intervention studies.
-
Discuss strategies for new treatment development.
-
Review the status of genetic findings.
-
Discuss methods to advance genetic research in schizophrenia.
-
Review brain imaging data in relation to pathophysiology and disease pregression.
Translate basic neuroscience findings of relevance to clinical practice.
Understand differences in schizophrenia research and outcome of the research across diverse geographic areas and cultures.
| 
